Cargando…

Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy

Detalles Bibliográficos
Autores principales:	Stone, Elizabeth F., Avecilla, Scott T., Wuest, David L., Lomas-Francis, Christine, Westhoff, Connie M., Diuguid, David L., Sadelain, Michel, Boulad, Farid, Shi, Patricia A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776235/ https://www.ncbi.nlm.nih.gov/pubmed/32817291 http://dx.doi.org/10.3324/haematol.2020.253229

Ejemplares similares

Safety and efficacy of plerixafor dose escalation for the mobilization of CD34(+) hematopoietic progenitor cells in patients with sickle cell disease: interim results
por: Boulad, Farid, et al.
Publicado: (2018)

Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal
por: Thein, Swee Lay, et al.
Publicado: (2020)

A case of delayed hemolytic transfusion reaction in sickle cell disease patient
por: Dogra, Ashu, et al.
Publicado: (2016)

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease: A Case Series
por: Alwaheed, Abrar J., et al.
Publicado: (2022)

An Unusual Case of Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-Jk(b) and Anti-Fy(a) Alloantibodies
por: El Alaoui, Kenza, et al.
Publicado: (2022)

Delayed Hemolytic Transfusion Reaction in a Patient with Sickle Cell Disease: Case Report
por: Omer, Sawsan A, et al.
Publicado: (2020)

Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease
por: Floch, Aline, et al.
Publicado: (2020)

Delayed Hemolytic Transfusion Reaction in a Sickle Cell Disease Patient: A Case Report
por: Saleh, Mohammed, et al.
Publicado: (2020)

Two Consecutive Episodes of Severe Delayed Hemolytic Transfusion Reaction in a Sickle Cell Disease Patient
por: Mpinganzima, Clarisse, et al.
Publicado: (2020)

Delayed hemolytic transfusion reaction in children with sickle cell disease: first 5-year retrospective study in mainland France
por: Falguière, Claire, et al.
Publicado: (2022)

Identification of Anti-Gerbich Antibody in an Emirati Marrow Hematopoietic Progenitor Cell Donor with Fy(a−b−) Phenotype
por: Choi, Seung Jun, et al.
Publicado: (2018)

Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease and the Role of the Classical Complement Pathway: A Case Report
por: Hair, Pamela S., et al.
Publicado: (2021)

Red cell transfusion and alloimmunization in sickle cell disease
por: Linder, Grace E., et al.
Publicado: (2021)

Red blood cell transfusion in sickle cell disease
por: Uminski, Kelsey, et al.
Publicado: (2023)

Treasurer's Report for FY 2008
por: Archibald, John M.
Publicado: (2010)

Treasurer's Report for FY 2009
por: Archibald, John M.
Publicado: (2010)

Treasurer’s Report for FY 2010
por: Archibald, John M.
Publicado: (2012)

Hematopoietic Cell Transplantation for Sickle Cell Disease
por: Krishnamurti, Lakshmanan
Publicado: (2021)

Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion
por: Lagresle-Peyrou, Chantal, et al.
Publicado: (2018)

Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene Therapy
por: Arnold, Danielle E., et al.
Publicado: (2022)

Opioid prescribing and use in the Military Health System: a framework synthesis, FY2016–FY2021
por: Madsen, Cathaleen, et al.
Publicado: (2023)

Best practices for transfusion for patients with sickle cell disease
por: Wun, Ted, et al.
Publicado: (2010)

Transfusion therapy for sickle cell disease: what’s new?
por: Chou, Stella T., et al.
Publicado: (2022)

COVID-19: an FY1 on the frontline
por: Jeyabaladevan, Priyancaa
Publicado: (2020)

Reclassification of Enterobacter sp. FY-07 as Kosakonia oryzendophytica FY-07 and Its Potential to Promote Plant Growth
por: Gao, Ge, et al.
Publicado: (2022)

Alloimmunization against Fy3 is a serious threat in the era of cell therapy
por: Lemaire, Baptiste, et al.
Publicado: (2022)

The hematopoietic saga of clonality in sickle cell disease
por: Stonestrom, Aaron J., et al.
Publicado: (2022)

Transfusion support in hematopoietic stem cell transplantation
por: Jekarl, Dong Wook, et al.
Publicado: (2023)

Hematopoietic Stem Cell Function in a Murine Model of Sickle Cell Disease
por: Javazon, Elisabeth H., et al.
Publicado: (2012)

Neurological Complications following Blood Transfusions in Sickle Cell Anemia
por: Alharbi, Hana, et al.
Publicado: (2017)

Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
por: Lakkaraja, Madhavi, et al.
Publicado: (2022)

Treasurer’s Report for Financial Year (FY) 2011
por: McLysaght, Aoife
Publicado: (2013)

Treasurer’s Report for Financial Year (FY) 2012
por: McLysaght, Aoife
Publicado: (2013)

Treasurer’s Report for Financial Year (FY) 2013
por: McLysaght, Aoife
Publicado: (2014)

Treasurer’s Report for Financial Year (FY) 2016
por: de Meaux, Juliette
Publicado: (2017)

Treasurer’s Report for Financial Year (FY) 2020
Publicado: (2021)

Treasurer’s Report for Financial Year (FY) 2019
por: Thorne, Jeffrey L., et al.
Publicado: (2021)

Treasurer’s Report for Financial Year (FY) 2021
por: McCutcheon, John P, et al.
Publicado: (2022)

Manual red cell exchange transfusion to avert sickle cell related complications
por: Mehra, Ruhi A., et al.
Publicado: (2018)

Mobilizing hematopoietic progenitor cells in donors with sickle cell trait is safe
por: De Santis, Gil Cunha, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uf0kcfcs7depofed95m14hqojo